• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SC 13G/A filed by Quipt Home Medical Corp.

    12/11/24 4:06:42 PM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care
    Get the next $QIPT alert in real time by email
    SC 13G/A 1 quipt_sc13ga.htm SC 13G/A quipt_sc13ga.htm

      

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    SCHEDULE 13G

    Under the Securities Exchange Act of 1934

     

    (Amendment No.1)*

     

    Quipt Home Medical Corp.

    (Name of Issuer)

     

    Common Stock

    (Title of Class of Securities)

     

    74880P104

    (CUSIP Number)

     

    September 30, 2024

    (Date of Event Which Requires Filing of this Statement)

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     

     

    ☐

    Rule 13d-1(b)

     

     

     

     

    ☒

    Rule 13d-1(c)

     

     

     

     

    ☐

    Rule 13d-1(d)

     

    *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

     

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     

     

    CUSIP No. 74880P104

    Page 2 of 7 Pages

     

    1

    NAME OF REPORTING PERSONS

     

    Forager Fund, L.P.

    2

     

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)

     

    (a) ☐ (b) ☐

    3

     

    SEC USE ONLY

     

     

    4

     

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Delaware

      

     

    NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY EACH REPORTING

    PERSON

    WITH

    5

     

    SOLE VOTING POWER

     

    4,192,562

    6

     

    SHARED VOTING POWER

     

    0

    7

     

    SOLE DISPOSITIVE POWER

     

    4,192,562

    8

    SHARED DISPOSITIVE POWER

     

    0

      

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    4,192,562

    10

     

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions)

     

    ☐

    11

     

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    9.7%(1)

    12

     

    TYPE OF REPORTING PERSON (See Instructions)

     

    PN

     

    (1)

    Calculated based on 43,090,000 shares of common stock of the Issuer as of June 30, 2024, as reported on the Issuer’s Report of Foreign Private Issuer on Form 6-K for the period ended June 30, 2024, filed on August 14, 2024.

     

     

     

     

    CUSIP No. 74880P104

    Page 3 of 7 Pages

     

    1

    NAME OF REPORTING PERSONS

     

    Forager Capital Management, LLC

    2

     

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)

     

    (a) ☐ (b) ☐

    3

     

    SEC USE ONLY

     

     

    4

     

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    Delaware

      

     

    NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY EACH REPORTING

    PERSON

    WITH

    5

     

    SOLE VOTING POWER

     

    4,192,562(1)

    6

     

    SHARED VOTING POWER

     

    0

    7

     

    SOLE DISPOSITIVE POWER

     

    4,192,562(1)

    8

    SHARED DISPOSITIVE POWER

     

    0

      

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    4,192,562(1)

    10

     

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions)

     

    ☐

    11

     

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    9.7%(2)

    12

     

    TYPE OF REPORTING PERSON (See Instructions)

     

    IA

     

    (1)

    Shares reported in this table are held by Forager Fund, L.P., of which the Reporting Person is the general partner.

    (2)

    Calculated based on 43,090,000 shares of common stock of the Issuer as of June 30, 2024, as reported on the Issuer’s Report of Foreign Private Issuer on Form 6-K for the period ended June 30, 2024, filed on August 14, 2024.

     

     

     

     

    CUSIP No. 74880P104

    Page 4 of 7 Pages

     

    1

    NAME OF REPORTING PERSONS

     

    Edward Kissel

    2

     

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)

     

    (a) ☐ (b) ☐

    3

     

    SEC USE ONLY

     

     

    4

     

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    USA

      

     

    NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY EACH REPORTING

    PERSON

    WITH

    5

     

    SOLE VOTING POWER

     

    0

    6

     

    SHARED VOTING POWER

     

    4,192,562(1)

    7

     

    SOLE DISPOSITIVE POWER

     

    0

    8

    SHARED DISPOSITIVE POWER

     

    4,192,562(1)

      

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    4,192,562(1)

    10

     

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions)

     

    ☐

    11

     

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    9.7%(2)

    12

     

    TYPE OF REPORTING PERSON (See Instructions)

     

    HC; IN

     

    (1)

    These shares are held by Forager Fund, L.P., of which Forager Capital Management, LLC is the general partner. The Reporting Person is a managing partner of Forager Capital Management, LLC.

    (2)

    Calculated based on 43,090,000 shares of common stock of the Issuer as of June 30, 2024, as reported on the Issuer’s Report of Foreign Private Issuer on Form 6-K for the period ended June 30, 2024, filed on August 14, 2024.

     

     

     

     

    CUSIP No. 74880P104

    Page 5 of 7 Pages

     

    1

    NAME OF REPORTING PERSONS

     

    Robert MacArthur

    2

     

    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)

     

    (a) ☐ (b) ☐

    3

     

    SEC USE ONLY

     

     

    4

     

    CITIZENSHIP OR PLACE OF ORGANIZATION

     

    USA

      

     

    NUMBER OF

    SHARES

    BENEFICIALLY

    OWNED BY EACH REPORTING

    PERSON

    WITH

    5

     

    SOLE VOTING POWER

     

    0

    6

     

    SHARED VOTING POWER

     

    4,192,562(1)

    7

     

    SOLE DISPOSITIVE POWER

     

    0

    8

    SHARED DISPOSITIVE POWER

     

    4,192,562(1)

      

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

    4,192,562(1)

    10

     

    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions)

     

    ☐

    11

     

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

    9.7%(2)

    12

     

    TYPE OF REPORTING PERSON (See Instructions)

     

    HC; IN

     

    (1)

    These shares are held by Forager Fund, L.P., of which Forager Capital Management, LLC is the general partner. The Reporting Person is a managing partner of Forager Capital Management, LLC.

    (2)

    Calculated based on 43,090,000 shares of common stock of the Issuer as of June 30, 2024, as reported on the Issuer’s Report of Foreign Private Issuer on Form 6-K for the period ended June 30, 2024, filed on August 14, 2024.

     

     

     

     

    CUSIP No. 74880P104

    Page 6 of 7 Pages

     

    ITEM 1(a).

    NAME OF ISSUER

     

     

     

    Quipt Home Medical Corp. (the “Issuer”)

     

     

    ITEM 1(b).  

    ADDRESS OF ISSUER’S PRINCIPAL EXECUTIVE OFFICES

     

     

     

    1019 Town Drive

     

    Wilder, Kentucky 41076

     

     

    ITEM 2(a).  

    NAME OF PERSONS FILING

     

     

     

    This joint statement on Schedule 13G is being filed by Forager Fund, L.P., a Delaware limited partnership (the “Fund”), Forager Capital Management, LLC, a Delaware limited liability company and the general partner of the Fund (the “General Partner”), Edward Kissel and Robert MacArthur (collectively, the “Reporting Persons”).

     

     

    ITEM 2(b).  

    ADDRESS OF PRINCIPAL BUSINESS OFFICE

     

     

     

    The business address of each of the Reporting Persons is 2025 3rd Ave. N, Suite 350, Birmingham, AL 35203.

     

     

    ITEM 2(c).  

    CITIZENSHIP

     

     

     

    The Fund is a Delaware limited partnership. The General Partner is a Delaware limited liability company. Each of Messrs. Kissel and MacArthur is a citizen of the United States.

     

     

    ITEM 2(d).  

    TITLE OF CLASS OF SECURITIES

     

     

     

    Common stock (the “Common Stock”).

     

     

    ITEM 2(e).  

    CUSIP NUMBER

     

     

     

    74880P104

     

     

    ITEM 3.  

    Not applicable.

     

     

    ITEM 4.  

    OWNERSHIP

     

     

     

    The Reporting Persons, in the aggregate, beneficially own 4,192,562 shares of Common Stock of the Issuer, representing approximately 9.7% of such class of securities. The beneficial ownership of each Reporting Person is as follows: each of the Fund, the General Partner and Messrs. Kissel and MacArthur beneficially owns 4,192,562 shares of Common Stock representing approximately 9.7% of the class. The percentages of beneficial ownership reported herein, and on each Reporting Person’s cover page to this Schedule 13G, are based on a total of 43,090,000 shares of Common Stock as of June 30, 2024, as reported on the Issuer’s Report of Foreign Private Issuer on Form 6-K for the period ended June 30, 2024, filed on August 14, 2024

     

     

     

    Each of the Fund and the General Partner has the sole power to vote and dispose of 4,192,562 shares of Common Stock. Each of Messrs. Kissel and MacArthur has the shared power to vote and dispose of 4,192,562 shares of Common Stock. The amounts and percentages of beneficial ownership reported herein are as of September 30, 2024.

     

     

     

     

    CUSIP No. 74880P104

    Page 7 of 7 Pages

     

    ITEM 5.

    OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS

     

     

     

    Not applicable.

     

     

    ITEM 6.

    OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON

     

     

     

    Not applicable.

     

     

    ITEM 7.

    IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY OR CONTROL PERSON

     

     

     

    Not applicable.

     

     

    ITEM 8.

    IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP

     

     

     

    Not applicable.

     

     

    ITEM 9.

    NOTICE OF DISSOLUTION OF GROUP

     

     

     

    Not applicable.

     

     

    ITEM 10.

    CERTIFICATION

     

     

     

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

     

     

     

     

    SIGNATURES

     

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

     

    Date:

    December 11, 2024

     

     

     

     

     

     

    FORAGER FUND, L.P.

     

         
    By:

    Forager Capital Management, LLC,

    its General Partner

     

     

     
      By: /s/ Robert MacArthur   
        Robert MacArthur

    Managing Partner

     

     

      FORAGER CAPITAL MANAGEMENT, LLC
           
    By: /s/ Robert MacArthur

     

     

    Robert MacArthur

    Managing Partner

     

     

     

    EDWARD KISSEL

     

       
    /s/ Edward Kissel

     

    Edward Kissel  
       
      ROBERT MACARTHUR  

     

     

     

     

    /s/ Robert MacArthur 

     

     

    Robert MacArthur

     

     

     

     

    Get the next $QIPT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $QIPT

    DatePrice TargetRatingAnalyst
    5/14/2025$1.70Buy → Hold
    Canaccord Genuity
    5/17/2024Mkt Perform → Underperform
    Raymond James
    2/16/2024Outperform → Mkt Perform
    Raymond James
    6/14/2023$11.00Buy
    Canaccord Genuity
    10/20/2021$7.50Buy
    The Benchmark Company
    10/20/2021$7.50Buy
    Benchmark
    More analyst ratings

    $QIPT
    SEC Filings

    View All

    SEC Form 10-Q filed by Quipt Home Medical Corp.

    10-Q - Quipt Home Medical Corp. (0001540013) (Filer)

    2/9/26 4:06:03 PM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    SEC Form DEFA14A filed by Quipt Home Medical Corp.

    DEFA14A - Quipt Home Medical Corp. (0001540013) (Filer)

    2/4/26 5:07:02 PM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    SEC Form DEFA14A filed by Quipt Home Medical Corp.

    DEFA14A - Quipt Home Medical Corp. (0001540013) (Filer)

    2/4/26 5:05:55 PM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    $QIPT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Quipt Home Medical downgraded by Canaccord Genuity with a new price target

    Canaccord Genuity downgraded Quipt Home Medical from Buy to Hold and set a new price target of $1.70

    5/14/25 8:58:24 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Quipt Home Medical downgraded by Raymond James

    Raymond James downgraded Quipt Home Medical from Mkt Perform to Underperform

    5/17/24 7:45:25 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Quipt Home Medical downgraded by Raymond James

    Raymond James downgraded Quipt Home Medical from Outperform to Mkt Perform

    2/16/24 8:29:00 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    $QIPT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President/CEO Crawford Gregory John exercised 583,500 shares at a strike of $1.11, increasing direct ownership by 21% to 3,351,196 units (SEC Form 4)

    4 - Quipt Home Medical Corp. (0001540013) (Issuer)

    12/15/25 7:26:34 PM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Director Wessel Brian Joseph was granted 183,135 shares, increasing direct ownership by 1,297% to 197,260 units (SEC Form 4)

    4 - Quipt Home Medical Corp. (0001540013) (Issuer)

    3/25/25 7:37:03 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Chief Accounting Officer Roehrig Thomas was granted 110,000 shares, increasing direct ownership by 175% to 173,000 units (SEC Form 4)

    4 - Quipt Home Medical Corp. (0001540013) (Issuer)

    3/25/25 7:36:22 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    $QIPT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Exec VP Operations Gamble Patrick Dennis bought $41,634 worth of shares (17,000 units at $2.45), increasing direct ownership by 74% to 40,057 units (SEC Form 4)

    4 - Quipt Home Medical Corp. (0001540013) (Issuer)

    12/30/24 4:05:11 PM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    $QIPT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Quipt Home Medical Corp. Announces Filing and Mailing of Proxy Statement and Information Circular and Receipt of Interim Order in Connection With Plan of Arrangement

    CINCINNATI, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. ("Quipt" or the "Company") (NASDAQ:QIPT, TSX:QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, is pleased to announce the filing of its definitive proxy statement and management information circular (the "Circular") in connection with Quipt's upcoming special meeting (the "Meeting") of the holders (the "Shareholders") of Quipt's common shares (the "Shares") to be held on March 3, 2026, at 10:00 a.m. (Eastern Standard Time). The Circular is available under Quipt's profile on SEDAR+ at www.sedarplus.com, with the U.S. Securities and Exchange Commission (the "SEC") on the EDGAR we

    2/4/26 5:00:00 PM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Quipt Home Medical Enters Into Definitive Agreement for Its Acquisition by Affiliates of Kingswood Capital Management and Forager Capital Management

    Quipt shareholders to receive US$3.65 per share in cashTransaction provides immediate liquidity and certainty of value to shareholdersThe per share purchase price represents a 162% premium to Quipt's unaffected stock price on May 19, 2025, the last full trading day prior to the public disclosure of Forager's $3.10 per share proposal, and a 54% premium to Quipt's 30-day VWAP as of December 12, 2025 CINCINNATI, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. ("Quipt" or the "Company") (NASDAQ:QIPT, TSX:QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, today announced that it has entered into a definitive agreement (the "Arrangement Agree

    12/15/25 7:30:00 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Quipt Home Medical Reports Fourth Quarter and Fiscal Year 2025 Financial Results

    CINCINNATI, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the "Company") (NASDAQ:QIPT, TSX:QIPT), a U.S.-based home medical equipment provider focused on end-to-end respiratory care, today announced its fourth quarter and fiscal year 2025 financial results and operational highlights. These results pertain to the three months and year ended September 30, 2025 and are reported in U.S. Dollars under GAAP. Financial Highlights: Revenue for Q4 2025 was $68.3 million compared to $61.3 million for Q4 2024, representing an 11% increase. Sequential organic revenue growth from Q3 2025 was strong at 5%.Recurring Revenue1 for Q4 2025 was strong at 80% of total revenue, driven by the gr

    12/15/25 7:30:00 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    $QIPT
    Leadership Updates

    Live Leadership Updates

    View All

    Quipt Home Medical Unveils Strategic Priorities for 2025 to Enhance Shareholder Value and Announces Voting Results from its Annual General Meeting

    CINCINNATI, March 24, 2025 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. ("Quipt" or the "Company") (NASDAQ:QIPT, TSX:QIPT)‎, a U.S. based home medical equipment provider, focused on end-to-end respiratory care, is pleased to announce its strategic priorities for calendar 2025 and the voting results from its annual general meeting of shareholders held on March 17, 2025 (the "Meeting") in Sarasota, Florida. The total number of shares represented in person or by proxy at the Meeting was 31,400,043, representing 72.87% of the total issued and outstanding shares in the capital of the Company. As it relates to its strategic priorities for 2025, the Company remains committed to returning to hist

    3/24/25 7:30:00 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Quipt Home Medical Announces Voting Results from Its Annual General and Special Meeting of Shareholders

    CINCINNATI, March 28, 2024 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the "Company") (NASDAQ:QIPT) (TSX:QIPT)‎, a U.S. based home medical equipment provider, focused on end-to-end respiratory care, today announced the voting results from its annual general and special meeting of shareholders held on March 27, 2024 (the "Meeting") in Wilder, Kentucky. The total number of shares represented in person or by proxy at the Meeting was 25,432,699, representing 60.4% of the total issued and outstanding shares in the capital of the Company. Election of Directors The four candidates nominated for election to the Company's Board of Directors (the "Board") and listed in the Company's manageme

    3/28/24 7:30:00 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Quipt Home Medical Announces New Independent Board Member

    CINCINNATI, Feb. 03, 2022 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. ("Quipt" or the "Company") (NASDAQ:QIPT, TSXV:QIPT), a U.S. based leader in the home medical equipment industry, focused on end-to-end respiratory care, announced today that Mr. Brian J. Wessel has joined the Board of Directors of the Company as an Independent Director and Chair of the Audit Committee. Mr. Wessel is a senior business executive with over 34 years of global client service, operational and financial expertise. As a former senior partner at Ernst & Young ("EY"), Mr. Wessel provided audit and advisory services to public, private, and private-equity-owned companies across multiple industry sectors. Additio

    2/3/22 7:30:00 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    $QIPT
    Financials

    Live finance-specific insights

    View All

    Quipt Home Medical Enters Into Definitive Agreement for Its Acquisition by Affiliates of Kingswood Capital Management and Forager Capital Management

    Quipt shareholders to receive US$3.65 per share in cashTransaction provides immediate liquidity and certainty of value to shareholdersThe per share purchase price represents a 162% premium to Quipt's unaffected stock price on May 19, 2025, the last full trading day prior to the public disclosure of Forager's $3.10 per share proposal, and a 54% premium to Quipt's 30-day VWAP as of December 12, 2025 CINCINNATI, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. ("Quipt" or the "Company") (NASDAQ:QIPT, TSX:QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, today announced that it has entered into a definitive agreement (the "Arrangement Agree

    12/15/25 7:30:00 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Quipt Home Medical Reports Improved Fiscal Third Quarter 2025 Results

    Posts Positive Organic Growth and Adjusted EBITDA‎1 of 23.5% of Revenue CINCINNATI, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. ("Quipt" or the "Company") (NASDAQ:QIPT, TSX:QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, today announced its fiscal third quarter 2025 financial results and operational highlights. These results pertain to the three and nine months ended June 30, 2025, and are reported in United States dollars. Conference Call Quipt will host its Earnings Conference Call on Tuesday, August 12, 2025 at 10:00 a.m. (ET). Interested parties may participate in the call by dialing 1 (833) 752-3722 or 1 (647) 846-85

    8/11/25 5:00:00 PM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Quipt Home Medical Corp. to Announce Fiscal Third Quarter 2025 Financial Results on August 11, 2025

    CINCINNATI, July 29, 2025 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the "Company") (NASDAQ:QIPT) (TSX:QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care, will announce its fiscal Third quarter 2025 financial results on Monday, August 11, 2025, after market close. Gregory Crawford, Chief Executive Officer, and Hardik Mehta, Chief Financial Officer, will host a conference call for the investment community on Tuesday, August 12, 2025, at 10:00 a.m. (ET). The call-in numbers for participants are:  Canada/US Toll Free:1 (833) 752 3722 International:1 (647) 846 8549    A live webcast of the call will be accessible via the investor

    7/29/25 7:30:00 AM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    $QIPT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D filed by Quipt Home Medical Corp.

    SC 13D - Quipt Home Medical Corp. (0001540013) (Subject)

    12/11/24 4:07:36 PM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    Amendment: SEC Form SC 13G/A filed by Quipt Home Medical Corp.

    SC 13G/A - Quipt Home Medical Corp. (0001540013) (Subject)

    12/11/24 4:06:42 PM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care

    SEC Form SC 13G filed by Quipt Home Medical Corp.

    SC 13G - Quipt Home Medical Corp. (0001540013) (Subject)

    12/11/24 4:06:09 PM ET
    $QIPT
    Misc Health and Biotechnology Services
    Health Care